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Abstract
Interferon-gamma(IFN-c),apotentTh1cytokinewithmultiplebiologicalfunctions,caninduceautophagytoenhancetheclearance
oftheinvadingmicroorganismorcausecelldeath.WehavereportedthatConcanavalin A(ConA)cancauseautophagiccelldeath
in hepatocytes and induce both T cell-dependent and -independent acute hepatitis in immunocompetent and immunodeficient
mice, respectively. Although IFN-c is known to enhance liver injury in Con A-induced hepatitis, its role in autophagy-related
hepatocyte death is not clear. In this study we report that IFN-c can enhance Con A-induced autophagic flux and cell death in
hepatomacelllines.Anecroticcelldeathwithincreasedlysosomalmembranepermeabilization(LMP)isobservedinConA-treated
hepatoma cells in the presence of IFN-c. Cathepsin B and L were released from lysosomes to cause cell death. Furthermore, IFN-c
inducesimmunityrelatedGTPasefamilyMmember1(IRGM1)translocationtolysosomesandprolongsitsactivityinConA-treated
hepatomacells.KnockdownofIRGM1inhibitstheIFN-c/ConA-inducedLMPchangeandcelldeath.Furthermore,IFN-c
2/2miceare
resistant to Con A-induced autophagy-associated necrotic hepatocyte death. We conclude that IFN-c enhances Con A-induced
autophagic flux and causes an IRGM1-dependent lysosome-mediated necrotic cell death in hepatocytes.
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Introduction
Programmed cell death has been classified as type I apoptosis and
type II autophagy-associated cell death [1]. Autophagy is an
evolutionarily conserved lysosomal pathway to generate energy by
digesting cytoplasmic proteins and organelles. Although autophagy
allows cells to survive from starvation or stress, an extended or
massive autophagy process turns to kill cells [2,3,4]. Necrosis is
usually considered as a non-programmed cell death without features
of apoptosis and autophagy [5,6]. However, necrosis can also be
regulated and controlled by cellular proteins, such as lysosomal
protease cathepsins [7]. Programmed celldeath can switch to necrosis
by inhibition of specific proteins of apoptosis or autophagy [6]. Cross-
regulation between these different types of cell death remains unclear.
Lysosomes are intracellular organelles which contain various
hydrolytic enzymes to control turnover of cellular macromolecules
and eliminate intracellular pathogens [8]. However, they can also be
responsible for mediating programmed cell death or necrosis [9].
Lysosome membrane permeablization (LMP) changes will initiate a
lysosome-mediated cell death. When the lysosome membrane is
damaged through LMP, cathepsins or other hydrolytic enzymes will
be released from lysosomes to the cytosol and cause cell death [10].
Autophagy is a lysosome-dependent pathway and can cause a type II
programmed cell death. Accumulated lysosomes or autophagolyso-
somes are increased in autophagy-associated cell death. However, the
role of LMP on autophagy-associated cell death is poorly understood.
Interferon-gamma (IFN-c), a major Th1 cytokine, is an
important mediator for immune-mediated hepatitis [11,12]. A
p53-dependent cell cycle arrest and apoptosis caused by IFN-c in
hepatocytes is suggested [13]. However, IFN-c can also regulate the
autophagic response to eliminate intracellular pathogen infection in
macrophages or cause cell death of epithelial cells [14,15]. The
immunity related GTPase family proteins (IRG), particularly
IRGM1, have been considered as key mediators for IFN-c-induced
autophagy [16]. We have reported that Concanavalin A (Con A)
can induce both T cell-dependent and T cell-independent acute
hepatitis [17]. A Bcl-2/adenovirus E1B 19 kDa-interacting protein
3 (BNIP3)-related mitochondria autophagy was involved in the
hepatocyte death [18]. In this study, we further report that IFN-c
can enhance Con A-induced autophagic flux and hepatocyte death.
The enhanced cell death by IFN-c/Con A represents a lysosomal
proteases, cathepsin B- and cathepsin L-dependent necrosis.
IRGM1 participates in this IFN-c-stimulated LMP-associated
necrosis in Con A-treated hepatocytes.
Results
IFN-c enhances autophagic flux and causes necrotic type
cell death in Con A-treated hepatocytes
Autophagic flux is a continuing process from autophagosome
generation to cargo degradation. We have reported that Con A
induced an acute hepatitis via a BNIP3 dependent mitochondria
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autophagosomes can be found in Con A-treated ML-14a cells but
reduced in the presence of autophagy inhibitor, 3-methylade-
nine, from electron microscopy (Figure S1). This pathway is
further extended to autophagic flux and is enhanced by IFN-c.
The BNIP3 was induced by Con A or IFN-c alone, and
enhanced while co-treatment in ML-14a cells. However, only
slightly increase of BNIP3 expression was detected at 12 hours
post treatment of IFN-c/Con A in HepG2 cells, which might be
due to the high level of basal BNIP3 expression in HepG2 cells.
The LC3-II conversions were both slightly increased in IFN-c/
Con A-treated ML-14a or HepG2 cells (Figure 1A). We next used
GFP-LC3 processing to follow autophagic flux, and an increase
of free GFP from GFP-LC3 processing was found in IFN-c/Con
A-treated ML-14a or HepG2 cells (Figure 1B). This suggests that
IFN-c enhances the autophagic flux on Con A-treated hepatoma
cells. We next determined the effect of IFN-c on Con A-induced
autophagic cell death. Con A dose-dependently induced HepG2
and ML-14a cell death, the addition of IFN-c significantly
enhanced the Con A-induced cell death, especially at the low
dose of 5–10 mg/ml of Con A (Figure 1C). The increase of cell
death by IFN-c on Con A-induced cell death was diminished by
3-methyadenine (autophagic inhibitor) or LC3 siRNA, but not
by Z-Vad-fmk (apoptosis inhibitor), suggesting that this enhance-
ment in cell death is not due to apoptosis (Figure 1D and 1E). To
further confirm this phenomenon, we monitored the fragmented
DNA from apoptotic cells by propidium iodide (PI) staining. The
apoptotic inducer, puromycin, induced fragmented DNA with
increase of sub G1 population in ML-14a ells. Instead, no such
increased-sub G1 population was detected in Con A-, IFN-c-o r
IFN-c/Con A- treated ML-14a cells, suggesting that these cells
were not died by apoptosis (Figure S2). These data indicate that
IFN-c enhances Con A-induced autophagic cell death in
hepatocytes. Con A alone-induced cell death can be easily
detected by propidium iodide or eosin Y exclusion assay (data
not shown), but not by LDH release, a feature of necrotic cell
death with detection in the culture supernatant. However, early
fusion of autophagosomes and lysosomes by IFN-c in Con A-
Figure 1. IFN-c enhances autophagic flux and cell death in Con A -treated hepatoma cell lines. A. Con A/IFN-c induces autophagy in
hepatoma cells. ML-14a and HepG2 cells were treated with PBS, Con A, IFN-c or IFN-c/Con A and then collected cell lysates at indicated time. The
expressions of phospho-STAT1, STAT1, BNIP3, LC3-I and LC3-II were determined by Western blot. B. Generation of free GFP from pGFP-LC3-expressed
hepatoma cells by ConA/IFN-c treatment. pGFP-LC3-transfected ML-14a or HepG2 cells were treated with Con A and IFN-c for 24 hours. The cell
lysates were extracted to determine expression of GFP-LC3 and free GFP by Western blot. C, IFN-c enhances Con A-induced cell death in hepatoma
cells. HepG2 and ML-14a cells were treated with various concentrations of Con A in the presence or absence of IFN-c for 24 hours. Cell death was
determined by propidium iodide staining and analyzed by flow cytometry. D and E. IFN-c enhances autophagy-dependent cell death in Con A-
treated hepatoma cells. ML-14a cells were pre-incubated with 3-methyladenine or Z-Vad-fmk (D), or transfected with control or LC3 siRNA (E). Then
these cells were co-treated with Con A and IFN-c for 24 hours. The knock down effect of LC3 was monitored by Western blot. The cell death of all
treatments was determined by propidium iodide staining. All results are representative of two to three experiments. * shows statistically significant
differences relative to PBS group. (p,0.05).
doi:10.1371/journal.pone.0028323.g001
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might be induced (Figure 2A). As results showed in Fig. 2B, we
can detect the LDH release in Con A and IFN-c treated
hepatoma cells. Another marker of necrosis, the release of
nuclear protein, HMGB1, was also found to be released from
Con A -treated hepatoma cells, and IFN-c could enhanced this
release (Figure 2C). Furthermore, IFN-c can increase Annexin
V/PI double positive cell population, which suggests as necrotic
cells, of Con A-treated ML-14a cells, and pretreatment of 3-
methyladenin will reduce this enhancement (Figure S3). AG490
(Jak2 inhibitor), or bafilomycin A1 (autophagic flux inhibitor)
both inhibited the IFN-c-triggered LDH release in Con A-
treated hepatoma cells (Figure 2D). These results suggest that
IFN-c can enhance Con A-induced autophagic flux and cause a
necrotic type cell death.
IFN-c causes a necrotic cell death with increase of
lysosomal membrane permeabilization (LMP) in Con A-
treated hepatocyte
We next determined how IFN-c enhances Con A-induced
necrotic type cell death. The LMP was determined by acridine
orange (AO), a lysosomotropic fluorochrome used to measure
cellular increase of the LMP. AO-stained normal cells showed red
punctate on microscopic observation and intact red fluorescence
on flow cytometry. The Con A or IFN-c treatment alone have the
same pattern with that of normal cells. However, IFN-c plus Con
A caused a dramatic loss of the punctate staining and red
fluorescence on AO-stained hepatoma cells compared with the
Con A or IFN-c treatment groups (Figure 3A). We also found that
the lysosomal proteases, cathepsin B and L, were released into the
cytoplasm. They are normally localized in LAMP1-positive
Figure 2. IFN-c causes necrotic type cell death in Con A-treated hepatoma cell lines. A. The colocalization of punctate LC3 and LAMP-1 in
ML-14a cells. ML-14a cells were treated with PBS, Con A, IFN-c or IFN-c/Con A for 6 hours. All cells were fixed and stained with anti-LC3 or LAMP1
antibodies. The colocalization of punctate LC3 and LAMP 1 was assayed using confocal microscopy. Cell nucleus was stained with Hoechst (blue).
B and C. IFN-c triggers LDH and HMGB1 release from Con A-treated hepatoma cells. ML-14a was treated with Con A at various doses in the presence
or absence of IFN-c for 24 hours. The cell supernatants were then collected, the LDH (B) was determined with enzymatic activity as described in
Materials and Methods while the HMGB1 (C) was determined by Western blot. C: total cell lysate; M: culture supernatant in media. D. IFN-c-caused
LDH release in Con A-treated hepatoma cells is JAK2- and autophagy-dependent. ML-14a cells were pre-incubated with DMSO, AG490 or bafilomycin
A1 (baf) for 1 hour and then co-treated with Con A and IFN-c for another 24 hours. The activity of LDH in cell culture supernatants was determined.
All results are representative of two to three experiments.* shows statistically significant differences relative to RPMI or DMSO group. (p,0.05).
doi:10.1371/journal.pone.0028323.g002
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increases of LAMP1-negative cathepsin B or L were found in the
cytosol, indicating that cathepsin B and L were released following
the IFN-c plus Con A-induced increment of LMP (Figure 3B). We
further determined whether cathepsin can mediate the IFN-c-
triggered necrosis of Con A-treated hepatoma cells. Using several
specific inhibitors to block the IFN-c plus Con A-induced LDH
release and LMP increment, we found that inhibitors of cathepsin
B (Z-Phe-Phe-CH2F) and L (CA-074Me), but not an inhibitor of
cathepsin D (pepstatin A), can inhibit the IFN-c-induced LDH
release and increase of LMP in Con A-treated hepatoma cells
(Figure 3C and 3D). To further verify the role of cathepsin B, L
and autophagy in the IFN-c-triggered necrotic cell death, the
siRNA of cathepsin B, L and LC3 were used. The IFN-c/Con A
induced LDH release was inhibited by cathepsin B, L and LC3
siRNA treatment (Figure 3E). These results suggest that IFN-c-
induced LMP causes cathepsin B and L-dependent necrotic cell
type death in Con A-treated hepatoma cells.
IRGM1 mediates IFN-c-enhanced LMP-associated
lysosomal cell death in Con A-treated hepatocytes
The immunity-related GTPase, IRGM1, is essential for IFN-c-
dependent anti-microbial function and autophagy induction [16].
Since IFN-c causes an autophagy-associated necrotic cell death in
Con A-treated hepatoma cells, we further studied the role of
IRGM1 on this phenomenon. To our surprise, Con A, not IFN-c,
enhanced a temporary increase of IRGM1 at 3 hours post
treatment in ML14a cells. However, the increased level of IRGM1
could be sustained to 12 hours in IFN-c/Con A-treated cells,
suggesting the IRGM1 expression were enhanced by IFN-c
(Figure 4A). With confocal microscopy observation, we found that
IRGM1 was co-localized with mitochondria-related protein,
Tom20, in IFN-c or IFN-c/Con A-treated ML-14a cells, but not
in PBS or Con A-treated cells. In addition to mitochondria
translocation, IRGM1 was found to co-localize with LAMP1 only
in IFN-c/Con A-treated cells, but not in IFN-c-treated cells
Figure 3. IFN-c induces a necrotic type cell death with increase of LMP in Con A-treated hepatoma cells. A. IFN-c causes increase of LMP
in Con A-treated hepatocytes. ML-14a cells were stained with acridine orange and treated with Con A and IFN-c. The red fluoresce of acridine orange
was observed in florescence microscope or analyzed by flow cytometry. B. IFN-c induces cathepsin-B/L release in Con A-treated hepatoma cells. After
treatment of Con A and IFN-c for 12 hours, ML-14a cells were fixed and stained with anti-cathepsin B, anti-cathepsin-L or anti-LAMP1 antibody or
extracted the cytosolic proteins by digitonin as described in Materials and Methods. The distribution of cathepsinB/L was analyzed using a confocal
fluorescence microscope or immunoblotting. Cell nucleus was stained with Hoechst (blue). C–E. Cathepsin B/L mediates IFN-c-induced LDH release
and increase of LMP in Con A-treated hepatoma cells. ML-14a cells were pretreated with DMSO or different cathepsin inhibitors (C,D) or transfected
with siRNA of control, LC3, cathepsin B or cathepsin L (E), and then treated with Con A and IFN-c for another 24 hours. The release of LDH and cellular
LMP in all treatments were both determined as described above. The knock down effect of cathepsin B and L were monitored by Western blot. All
results are representative of two to three experiments.* shows statistically significant differences relative to DMSO group. (p,0.05).
doi:10.1371/journal.pone.0028323.g003
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only the IRGM1 expression, but also translocation of IRGM1 to
lysosome. Furthermore, the IRGM1 expression was knocked
down by siRNA to further investigate its role in IFN-c/Con A-
induced LMP-associated necrosis (Figure 4C).We found that the
IFN-c/Con A-caused increase of LMP in hepatoma cells was
significantly inhibited by IRGM1 siRNA, suggesting that IRGM1
is involved in IFN-c/Con A-caused LMP change (Figure 4D).
Because the activity of cathepsin B and L is crucial for IFN-c/Con
A-caused LMP change and necrotic cell death as shown above,
and might be regulated by IRGM1. Indeed, the cytosolic
cathepsin B/L activity as well as the LDH release were also
abolished by IRGM1 siRNA in IFN-c/Con A-treated hepatoma
cells (Figure 4E and 4F). These results suggest that IRGM1
regulates the LMP change that releases the cathepsin B/L to
causes lysosomal cell death in IFN-c/Con A-treated hepatoma
cells.
IFN-c
2/2 mice are resistant to Con A-induced autophagy-
associated necrotic type cell death
To further evaluate this phenomenon in vivo, we compared the
Con A-induced hepatitis in IFN-c
2/2 mice with that in wild type
mice. In wild type mice, an intravenous injection of 40 mg/kg of
Con A increased the serum ALT, and necrosis in the liver was
observed by histological staining at 6 hours post injection, and the
mice finally die within 10 h. In contrast, the IFN-c
2/2 mice were
resistant to Con A-induced hepatitis, with less mortality, no
increase of serum ALT, and no necrosis in the liver (Figure 5A–
5C). We also found that the LC3-II conversion was induced in
Con A-treated wild type mice, but not in IFN-c
2/2 mice
Figure 4. IRGM1 mediates IFN-c-enhanced LMP-associated necrosis-like cell death in Con A-treated hepatoma cells. A. IRGM1
expression in IFN-c/Con A-treated hepatoma cells. ML-14a cells were treated with PBS, Con A, IFN-c or IFN-c/Con A and collected cell lysates at
indicated time. The expression of IRGM1 was determined by Western blot. B. IRGM1 translocates to mitochondria and lysosomes. After treatment of
Con A or IFN-c for 12 hours, ML-14a cells were fixed and stained with anti-IRGM1, Tom20, and LAMP-1 antibodies. The co-localization of IRGM1 and
Tom20 or LAMP-1 was analyzed using a confocal fluorescence microscope. Cell nucleus was stained with Hoechst (blue). C. Knock down of IRGM1 by
siRNA. ML-14a cells were transduced with siRNA of control or IRGM1 as described in Materials and Methods. The expression of IRGM1 was determined
by Western blot. D. Knock down of IRGM1 attenuates IFN-c-enhanced LMP in Con A-treated hepatoma cells. ML-14a cells were transduced with siRNA
of control or IRGM1 and treated with Con A and IFN-c. The cells were then stained with acridine orange to monitor the LMP. E. IRGM1 mediates IFN-c-
induced increase of cytosolic cathepsin B/L activities in Con A-treated hepatoma cells. After knock down of IRGM1 by siRNA, ML-14a cells were treated
with Con A and IFN-c and the cytosolic fraction was collected. The activities of cytosolic cathepsin B/L were then determined. F. IRGM1 mediates IFN-
c-enhanced LDH release from Con A-treated hepatoma cells. ML-14a cells were pretreated with siRNAs or bafilomycine A1 and then incubated with
Con A and IFN-c. The activity of LDH in cell culture supernatants was determined. All results are representative of two to three experiments.* shows
statistically significant differences relative to control group. (p,0.05).
doi:10.1371/journal.pone.0028323.g004
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inhibited in IFN-c
2/2 mice comparing with wild type mice at
6 hours post Con A injection (Figure 5E). This suggests that IFN-c
can enhance the Con A-induced necrotic type cell death in vivo.
Discussion
Autophagy is a cell survival system to protect cells from damage
by protein aggregates or injured organelles, but it can also lead to
cell death with characteristics of apoptosis or necrosis under
different conditions. We have previously reported that autophagic
induction resulted in hepatocyte death with Con A-induced acute
hepatitis. In this study we further showed that IFN-c, an important
mediator for immune-mediated liver injury, enhances the
autophagic flux and triggers a lysosomal cell death in Con A-
treated hepatocytes. This autophagy-dependent necrotic cell death
is mediated by IFN-c-related IRGM1-induced LMP to release
lysosomal proteases, cathepsin B/L.
IFN-c can induce hepatocytes to undergo cell arrest and
apoptosis after in vitro culture for 48 to 72 hours, where an IRF-1-
dependent caspase-3 and p53 expression mediates this IFN-c-
caused hepatocyte apoptosis [13]. IFN-c has also been shown to
enhance apoptosis with other cytokines or death-related receptors
[19,20,21]. In our study of the hepatoma ML-14a cell line, we
found neither any caspase-3 activation, nor any characteristics of
apoptosis within 24 hours post IFN-c treatment. Tagawa Y et al.
have reported that IFN-c would enhance Con A-induced
hepatocyte apoptosis on Con A-induced acute hepatitis in mice
[22]. In our earlier study, however, we reported that autophagy
occurred before the Con A-induced apoptosis in mice [17]. The
dose used can explain this discrepancy, as a higher dose (40 mg/
kg) of Con A is required to induce autophagy in mice. The LC3-II
conversion was found in wild type mice, but not in IFN-c2/2
mice (Figure 5D). The autophagy-related cell death has the
characteristics of LDH and HMGB1 release into the circulation.
Necrosis was found in the liver, with no immune cell infiltrations,
at 6 h post injection (Figure 5B). Therefore, the effect of IFN-c on
Con A-treated hepatocytes must be direct, and is not mediated by
the enhancement of immune cells. Our in vitro study demonstrates
that IFN-c can enhance the Con A-stimulated autophagic flux to
cause lysosomal cell death.
A massive breakdown of lysosomes could cause cell death by
necrosis, which is related to increase of cytosolic acidification [10].
IFN-c can regulate lysosome activities by the alteration of vacuolar
Figure 5. IFN-c
2/2 mice are resistant to Con A-induced autophagy-associated necrotic type cell death. A. Serum level of ALT on Con A-
treatedmice.WidetypeorIFN-c
2/2 micereceivedintravenousinjectionofCon Aandthe serumwerecollectedatindicatedtime.TheserumlevelofALT
was determined as described in Materials and Methods. (n=5) B. Histological staining of mice liver tissue. The liver tissues of wild type or IFN-c
2/2
mice were collected to stain with haematoxylin and eosin at indicated time post Con A injection. The arrow head indicates necrotic hepatocytes. C. IFN-
c
2/2 mice are resistant to Con A-induced mortality. Wild type or IFN-c
2/2 mice were injected intravenously with Con A and the survival was monitored.
(n=7)D. IFN-c
2/2 mice show reductionof Con A-inducedautophagy. Theliver extracts of wild type or IFN-c
2/2 mice were collected to detect the LC3-II
conversion by immune blotting at 3 hours post Con A injection. E. Serum level of LDH and HMGB1 on Con A-treated mice. Sera of Con A-treated wild
type or IFN-c
2/2 mice were collected at indicated time. The level of LDH or HMGB1 was determined as described above. (n=5) All results are
representative of two to three experiments. * shows statistically significant differences relative to control group. (p,0.05).
doi:10.1371/journal.pone.0028323.g005
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[23,24]. Here we found no significant increase in hepatocytes’
acidification and protein level of cathepsin B/L upon IFN-c
stimulation. Instead, small increase in cell acidification can be
detected at 6 hour post Con A treatment, which might lead to
activate cathepsins in lysosome (Figure S4.) However, this increase
in acidification is not enhanced by IFN-c, suggesting that other
factors are involved in IFN-c/Con A-caused necrosis. In this study
we further demonstrate that IFN-c enhances the autophagic flux
induced by Con A to cause LMP-associated necrotic cell death in
hepatocytes. In addition, the interferon-induced GTPase, IRGM1,
plays a crucial role to mediate this autophagy-associated necrosis.
IRGM1 is reported to recruit to pathogen-containing phagosomes
and autophagosomes, and to facilitate the acidification of theses
vacuoles and their fusion with lysosomes [16,25]. However, we did
not observe IRGM1 in autophagosomes in IFN-c/Con A-treated
hepatocytes (data not shown). Instead, IFN-c/Con A treatment
enhances or sustains the IRGM1 expression and causes its
redistribution to mitochondria and lysosomes, resulted in lysosome
membrane disruption. The redistribution of IRGM1 to lysosomes
has also been reported by Zhao et al. in IFN-c-induced mouse
embryonic fibroblasts [26]. How IRGM1 regulates lysosomal
membrane permeabilization remains further investigation. Hu-
man IRGM1 recently been reported to regulate IFN-c-induced
autophagy by binding mitochondrial lipid to control mitochon-
drial fission [27]. We have reported that accumulation of Con A
on mitochondria after endocytosis causes mitochondrial damage
and autophagy of damaged mitochondria [18]. In this study, we
further showed that co-localized of damaged mitochondria with
IRGM1 in IFN-c-treated murine hepatocytes, and its transloca-
tion to lysosome. Both Con A and IRGM1 binding to
mitochondria might increase mitochondria membrane damage
and enhance autophagolysosome process. Here we also found that
Con A can up-regulate IRGM1 expression in hepatocytes
(Figure 4A). Since BNIP3 is an important mediator to Con A-
induced autophagy, the interaction of IRGM1 and BNIP3 in
regulating autophagy process is worth to further study. The
lysosome-mediated cell death induced by IFN-c/Con A in
hepatocytes causes HMGB1 release. HMGB1 can act as an
inflammatory mediator to aggravate to inflammation-related
disease [28]. The autophagy-regulated HMGB1 release in tumor
cells, either in cell culture or in the serum of Con A-injected wild
type mice, is consistent with the observation of Thurhurn J et al.
[29].
Cell death with apoptotic or autophagic features can lead to
different immune responses [30]. Clearance of apoptotic cells is
considered to induce an anti-inflammatory reaction by produc-
tion of transforming growth factor-b (TGF-b), prostaglandin E2,
and platelet activating factor (PAF) [31]. Apoptotic cell death
induced by most chemotherapeutic drugs and radiation in cancer
therapy creates an immunosuppressive environment around the
tumor site, which may promote further tumor growth. Cell death
with autophagy stimulates a pro-inflammatory response that
subsequently activates the immune system and facilitates efficient
antigen cross-priming to CD8
+ T cells [32,33]. We have reported
that Con A with both autophagic induction and immuno-
modulation can generate a CD8
+ T cell-dependent anti-
hepatoma effect in mice [34]. These findings therefore support
the use of induction of autophagy as a new target for tumor
therapy. The release of HMGB1 post IFN-c/Con A treatment by
lysosomal cell death will provide a link to further anti-hepatoma
CD8
+ cytotoxic T cell activation. This is worthy of further
investigation.
Materials and Methods
Reagents and antibodies
Con A, pepstatin A, 3-methyladenine (3-MA) and E64D were
purchased from Sigma-Aldrich (St. Louis, MO, USA). The cell-
permeable cathepsin L inhibitor, Z-Phe-Phe-CH2F, and cathepsin
B inhibitor, CA-074Me, were purchased from Calbiochem (La
Jolla, California, USA). Control, cathepsin B and IRGM1 siRNA
were purchased from Sigma-Aldrich. Microtubule-associated
proteins light chain 3 (LC3) and cathepsin L siRNA were
purchased from Santa Cruz (Santa Cruz, CA, USA). The antisera
used were: anti-signal transducer and activator of transcription 1
(STAT1) and phospho-STAT1 (Tyr 701) from Cell Signaling
(Beverly, MA), anti- LC3 from MBL (Nagoya, Japan), anti-
mitochondrial preprotein translocases of the outer membrane 20
(Tom20) and anti-green fluorescent protein (GFP) from Santa
Cruz, anti-Bcl-2/adenovirus E1B 19 kDa-interacting protein 3
(BNIP3) from Sigma-Aldrich, anti-cathepsin B and anti-cathepsin
L from R&D system (Minneapolis, MN, USA), anti-lysosomal-
associated membrane protein 1 (LAMP 1) from ebioscience (San
Diego, CA, USA), anti-immunity-related GTPase (IRGM), anti-
high mobility group box 1 protein (HMGB1) and anti-b-actin
from Abcam (Cambridge, UK). The recombinant human and
murine interferon gamma were purchased from Peprotech (Rocky
Hill, NJ, USA).
Cell culture
The murine hepatoma cell line, ML-14a cell, was adapted from
ML-1 cells in BALB/c mice as previously described [18]. HepG2
cells were obtained from the Cell Collection and Research Center
(CCRC, Hsin-Chu, Taiwan). In inhibition experiments, the cells
were pre-treated with several inhibitors, including pepstatin A
(10 mg/ml), E64D (10 mg/ml), 3-MA (2 mM), Z-Vad-fmk
(100 mM), bafilomycin A1 (2 nM), AG490 (25 mM), Z-Phe-Phe-
CH2F (2 nM), and CA-074Me (50 mM), 1 h before addition of
Con A (20 mg/ml) or IFN-c (500 U/ml). Cell death was
determined by propidium iodide exclusion staining and analyzed
by flow cytometry. To detect the release of lactate dehydrogenase
(LDH) from cells, the cell culture supernatants were collected for a
LDH activity assay according to the guidelines of the detection
assay kit (Roche Diagnostics, Mannheim, Germany). To monitor
the status of lysosomal stability, ML-14a cells were stained with
1 mg/ml acridine orange at 37uC for 30 minutes. The red acridine
orange fluorescence was visualized by a fluorescent microscope or
analyzed by flow cytometry. ML-14a cells were planted on a cover-
slide and transfected with pGFP-LC3 or siRNAs using Lipofecta-
mine 2000 (Invitrogen Corp., Carlsbad, CA). Cells were fixed and
stained with primary antibody against LC3, IRGM1, Tom20,
LAMP-1, cathepsin B or cathepsin L followed by secondary
antibody conjugated with Alexa Fluor 488 or 594. The cellular
distribution of proteins was observed under a confocal fluores-
cence microscope (Olympus FV 1000, Japan).
Mice
C57BL/6 mice were provided by the Animal Center of
National Cheng Kung University (Tainan, Taiwan), and main-
tained in the pathogen-free facility of the Animal Laboratory of
National Cheng Kung University. The IFN-c
2/2 mice on a
C57BL/6 background were obtained from The Jackson Labora-
tory (Bar Harbor, ME). All animals were raised and cared for
according to the guidelines set up by the National Science Council,
ROC. The mouse experiments were approved by the institutional
animal care and use committee of National Chen Kung University
(IACUC approval No. 99159).To induce hepatitis, mice were
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weight, the serum being collected at various time points post
injection. The serum alanine aminotransferase (ALT) was
determined by using the Hitachi type 717 automatic analyzer
(Hitachi, Tokyo).
Western blot analysis
Cell lysates were prepared by extracting proteins with lysis
buffer (Cell Signaling, Beverly, MA). Proteins were separated by
SDS-PAGE and transferred to PVDF membranes. The mem-
branes were blocked and incubated with primary antibodies. After
incubation with peroxidase-conjugated secondary antibodies, the
blots were visualized by enhancing chemiluminescence reagents
(PerkinElimer Life Sciences, Boston, MA).
Analysis of cytosolic cathepsin B/L activity
To measure the cytosolic cathepsin B/L activity, the cytosolic
fraction was prepared as previously described [35]. In brief, the
treated or non-treated cells were harvested and washed with
phosphate buffered saline (PBS) twice. The digitonin-based
extraction buffer (50 mg/ml digitonin, 250 mM sucrose, 20 mM
HEPES, 10 mM KCl, 1.5 mM MgCl2, 1 mM EDTA, 1 mM
EGTA, pH 7.5) was added to cells and put on ice for 30 minutes.
The cytosolic fraction was then collected to measure cathepsin B/
L activity by InnoZymeTM Cathepsin L Fluorogenic Activity Kit
(Calbiochem) or to detect cathepsin B/L protein expression by
Western blotting as described above.
Supporting Information
Figure S1 Electron micrographs of Con A-treated ML-
14a cells. ML-14a cells were pretreated with 3-methyladenin (3-
MA) for 30 minutes and incubated with Con A for another
12 hours. A. The electron micrographs (610000) of PBS-, Con A-,
3-MA- and Con A/3-MA-treated ML-14a cells are presented. B.
The selected-areas of electron micrographs (660000) from Con A-
treated ML-14a cells are presented. M: mitochondria; AP:
autophagosome.
(TIF)
Figure S2 Analysis of apoptotic cells with sub G1
population in IFN-c/Con A-treated ML-14a cells. ML-14a
cells were treated with PBS, Con A, IFN-c, IFN-c/Con A or
puromycin for 24 hours. The cells were fixed with ethanol and
stained with PI to analyze the sub G1 population by flow
cytometry.
(TIF)
Figure S3 Autophagy contributes to IFN-c/Con A-
induced necrotic cell death. ML-14a cells were pretreated
with DMSO or 3-methyladenin for 30 minutes and incubated
with PBS, Con A, IFN-c, or IFN-c/Con A for another 24 hours.
The cells were harvested and stained with Annexin V-FITC/PI.
The cell population was analyzed by flow cytometry.
(TIF)
Figure S4 Acidification and total cathepsin B/L protein
expression in IFN-c/Con A-treated hepatocytes. A. ML-
14a cells were pretreated with DMSO or bafilomycin A1 (Baf) and
incubated with PBS, Con A, IFN-c, or IFN-c/Con A for another
6 hours. These cells were stained with AO for 30 minutes and
analyzed the acidification by flow cytometry. B. ML-14a cells were
with PBS, Con A, IFN-c, or IFN-c/Con A for 12 hours and
extracted the total cell lysates. The expression of cathepsin B and L
were determined by Western blot.
(TIF)
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